Subscribe to stay informed!
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal…
Devon’s Zynerba Pharmaceuticals, which develops synthetic cannabinoid therapies, is focusing on several rare and near-rare neurological and psychiatric disorders that have unmet medical…
Before we send you to this site, please subscribe to our daily newsletter.